Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Smoking cessation program and CYP2A6 polymorphism.

Shinichi Ozaki1, Tsunehiro Oyama, Toyohi Isse

  • 1Department of Environmental Health, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan.

Frontiers in Bioscience : a Journal and Virtual Library
|May 25, 2006
PubMed
Summary

Investigating CYP2A6 genotype and smoking cessation, this study found nicotine patch treatment effective. However, individuals with CYP2A6 gene deletion may experience more nicotine side effects and find quitting harder.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence and outcomes of pulmonary artery injury during anatomical lung resection for lung cancer: a nationwide database study in Japan.

Surgery today·2026
Same author

Preoperative and Intraoperative Localization of Small Pulmonary Nodules for Sublobar Resection: Practical Insights into Percutaneous, Bronchoscopic/Robotic, RFID (SuReFInD), and Hybrid-OR CT Workflows.

Diseases (Basel, Switzerland)·2026
Same author

Surgical treatment of acute empyema caused by methicillin-resistant <i>Staphylococcus aureus</i> in a patient with advanced non-small cell lung cancer: a case report.

Journal of surgical case reports·2026
Same author

PRDX4 expression potentially links redox adaptation to oncogenic signaling and tumor progression in pancreatic ductal adenocarcinoma.

Translational oncology·2026
Same author

Primary Gastric Adenocarcinoma with Thyroid Transcription Factor-1 Positivity Mimicking Gastric Metastasis from Lung Cancer: A Case Report.

Surgical case reports·2026
Same author

Immune Thrombocytopenia Successfully Controlled by Dissection of an Enlarged Mediastinal Lymph Node Metastasis from Squamous Cell Carcinoma of Unknown Primary: A Case Report.

Surgical case reports·2026

Area of Science:

  • Pharmacogenetics
  • Tobacco Control
  • Genetics

Background:

  • The link between CYP2A6 genotype and smoking behavior requires further clarification.
  • Understanding genetic influences on smoking cessation is crucial for personalized treatment strategies.

Purpose of the Study:

  • To investigate the impact of CYP2A6 genotype on smoking habits and nicotine patch treatment efficacy.
  • To explore the association between specific CYP2A6 variants and smoking cessation outcomes.

Main Methods:

  • Genotyping analysis of CYP2A6 gene variants in 41 smokers undergoing a cessation program.
  • Comparison of smoking cessation rates between nicotine patch users and non-users.
  • Analysis of genotype-specific differences in age, smoking duration, and nicotine dependence.

Related Experiment Videos

Main Results:

  • The overall 90-day smoking cessation rate was 54.1%.
  • Nicotine patch treatment significantly increased cessation rates (63.6%) compared to non-treatment (29.4%).
  • The CYP2A6 gene deletion homozygote (CYP2A619934/19934) incidence was potentially higher than in controls and associated with higher age and smoking years.

Conclusions:

  • Nicotine patch therapy is an effective smoking cessation aid.
  • Individuals with the CYP2A619934/19934 genotype may be more susceptible to nicotine adverse effects and face greater challenges in quitting.
  • CYP2A6 genotype may influence smoking cessation success and treatment response.